Background: Metalloprotease FtsH is involved in quality control of membrane proteins Results: Simultaneous (or sequential) expression of misfolded DrrAB and FtsH results in significant recovery of DrrAB-mediated doxorubicin efflux function.
assemble (4) . It was also shown that interaction between DrrA and DrrB is essential for stable maintenance of DrrB in the membrane so that the expression of DrrB is undetectable in the absence of a simultaneous expression of DrrA (2) . Coexpression of DrrA in cis or trans restores the wild-type levels of DrrB expression, therefore suggesting that DrrA protects DrrB from proteolysis by a cellular protease. The nature of the protease and whether it plays a specific role in quality control and biogenesis of the DrrAB complex has so far remained uncharacterized. In this study, we examine the role of FtsH (filament temperature-sensitive protein H) in this process.
FtsH is a zinc-dependent metalloprotease which belongs to the AAA (ATPases Associated with Diverse Cellular Activities) family of proteins. Along with other proteases, such as ClpAP, ClpXP, HsIUV, and Lon, these proteins form the large AAA + superfamily of proteins, members of which share a similar AAA-ATPase domain (5) . FtsH is evolutionarily conserved with more than 40% sequence identity observed between bacterial, yeast and human homologs (6) . E. coli FtsH is the best studied of all known members, and it has been shown to be the only growth-essential protease in E. coli. Yeast cells lacking the three FtsH orthologs (two m-AAA and one i-AAA) were also found to be non-viable, demonstrating the essential function of this enzyme in eukaryotic cells (6, 7) . FtsH is unique in being embedded in the cell membrane in E. coli, and in the mitochondrial inner membrane in eukaryotes (8) , where it forms homohexameric ring-like structures. The major role of FtsH is believed to be in the quality control of specific membrane proteins, such as degradation of the unassembled SecY and subunit 'a' of F 0 sector of the ATP synthase, in addition to modulating levels of some soluble regulatory proteins (8) (9) (10) .
FtsH contains two transmembrane helices at the N terminus, followed by a cytoplasmic domain containing the catalytic AAA domain in the middle and the proteolytic domain at the C terminus. The AAA domain (residues 144-398) consists of the conserved Walker A, Walker B and SRH (second region of homology) motifs, which are essential for ATP binding and hydrolysis (8) . The proteolytic domain contains the conserved Zn 2+ binding motif H 417 EXXH 421 , the third Zn 2+ -ligand residue E 479 , and the coiled-coil leucinezipper sequence (8) . FtsH carries out proteolysis of polypeptides in an ATP and Zn
2+
-dependent manner, while other AAA+ proteases, such as Lon and ClpA/P, are serine peptidases (11) . To initiate proteolysis of a membrane protein, the putative polypeptide binding site in the catalytic AAA domain of FtsH is believed to capture the cytoplasmic tail (either at the N or the C terminus) of the membrane substrate, followed by dislocation and processive unfolding of the protein to an open structure (8) . Therefore, both the catalytic AAA domain and the proteolytic domain are required for proteolysis.
Although the major function of the AAA + proteases is in proteolysis, they also exhibit chaperone-like activities, which allow them to monitor the folding status of a protein, promote disassembly or unfolding (12) , and specifically degrade non-native proteins (13) . For a long time, it has been speculated that the AAA + proteases may also have the ability to refold their substrate proteins (14) , which remains an open question till date (15) . FtsH was originally identified by Ito and co-workers in a screen to isolate factors which may assist in membrane protein assembly (16) . They used SecY-PhoA fusion to screen for stoptransfer defect (Std) mutations, and found that such a mutation lies in the ftsH gene. Depletion of FtsH also resulted in significant export defects of β-lactamase and OmpA in E. coli in addition to causing a strong Std phenotype. Together, these studies indicated that FtsH may be involved in protein assembly into and through the membrane and may play a role in determining orientation of membrane proteins (16) . In another study, FtsH orthologs Yta10 and Yta12 in yeast mitochondria were shown to be required for the formation of a 48 kDa assembly intermediate of the F 0 subunit 9 (17). Finally, in vitro studies showed that the purified AAA domain of Yme1, a yeast mitochondrial homolog of FtsH, suppresses aggregation of a model polypeptide (18) . Despite these observations, however, no direct evidence for the role of FtsH or its homologs in functional assembly of membrane proteins has been obtained so far.
In this study, we provide the first direct evidence that FtsH is a dual function enzyme containing both the protease and assembly functions. We show that not only is FtsH responsible for removal of the unassembled DrrB but that it is actually able to refold previously misassembled DrrAB proteins and restore Dox efflux function of the complex. Our results also show that while the AAA domain of FtsH provides recognition and specificity for binding of the substrate, both ATP hydrolysis and the proteolytic functions of FtsH are used concurrently for refolding of DrrAB and restoration of function. Our studies, therefore, not only shed light on the mechanism of assembly of the DrrAB complex but also further elucidate the function of the FtsH protease.
EXPERIMENTAL PROCEDURES
Strains and plasmids -The E. coli strains and plasmids are described in Table 1 . Media and growth conditions -E. coli cells were normally grown in LB medium at 30°C or 37 °C, unless indicated otherwise. Chloramphenicol, kanamycin, or ampicillin was added to a final concentration of 20, 30 or 100 µg/ml, respectively, where indicated. E. coli cells used for the Dox efflux assay were grown in TEA medium (3) . Table S1 . Subcloning of the AAA domain of ftsH into pUC18 vector -To completely remove the proteolytic domain, a fragment of ftsH corresponding to the first 1194 base pairs was PCR-amplified and ligated into the pUC18 vector using the EcoRI and HindIII restriction enzymes resulting in pUC18(AAA). This construct is referred to as ftsH(AAA) in this article. The primers are shown in Table S1 . Subcloning of ftsH and the groESL genes-Wildtype ftsH, ftsH(K198N), ftsH(HEH) and ftsH(AAA) genes were subcloned into pET28a vector using SnaBI and HindIII restriction enzymes. The resulting plasmids were named pETftsH, pETftsH(K198N), pETftsH(HEH) and pETftsH(AAA), respectively. The groES/L genes were subcloned from pKY326 (19) into pUC18 vector using EcoRI and SmaI restriction enzymes resulting in pUCgroESL Cloning of ftsH into the pBAD vector-Using pBAD/HisA (Invitrogen) as a template, a 3.9kb fragment between NcoI and HindIII sites was amplified. The NcoI site was substituted with the XhoI site in the primers used for amplification (Table S1 ). This resulted in deletion of the multiple cloning sites and the polyhistidine region. The ftsH gene was amplifed from pUCftsH using primers containing XhoI and HindIII sites and ligated to the above fragment. Growth and Protein expression -E. coli TG1, AR796, AR797, E. coli SG1110, and E. coli SG1126 cells containing the indicated plasmids were grown at 30 °C or 37 °C to mid-log phase (A 600nm =0.6). The proteins were induced by addition of 0.1 or 0.25 mM IPTG, and the incubation was continued at 30 °C, 37 °C, or 42 °C for 3 h. The cells were spun down, resuspended in 5 ml lysis buffer (2 mM Tris-Cl, pH 7.5, 20% glycerol, 2mM EDTA, 1 mM DTT) and lysed by a single passage through a French pressure cell at 20,000 p.s.i. After centrifugation at 10,000 X g for 15 min, the pellet represented the inclusion body fraction. The supernatant was centrifuged at 100,000 X g for 1 h to separate the supernatant (cytosolic fraction) and the pellet (membrane fraction). The membrane, cytosol and the inclusion body fractions were analyzed by 12% SDS-PAGE, followed by Western-blot analysis using anti-DrrA or anti-DrrB antibodies (2) . Purification of the FtsH protein -FtsH protein was purified according to published protocols (9) with modifications. E. coli HMS174(DE3) cells containing the pETftsH plasmid or its variants were inoculated in 1liter LB medium supplemented with 30 µg/ml kanamycin at 37 °C. The cells were grown to mid-log phase and induced with 0.25 mM IPTG at 20 °C overnight. The membrane fraction was prepared as described earlier (2). 5 mg of the membrane fraction was solubilized with 5 ml solubilization buffer (50 mM Tris-Cl, pH7.5, 500 mM KCl, 0.5 % (w/v) Nonidet P-40, 15% (w/v) Glycerol, 2.9 mM 2-mercaptoethanol). The solubilized protein was purified using Ni 2+ -NTA-agarose column and eluted with a gradient of 50 to 500 mM imidazole.
Site-directed mutagenesis of ftsH -
Fractions containing FtsH were collected and dialyzed against 2 liters of the dialysis buffer (10 mM Tris-Cl, pH7.5, 15% (w/v) glycerol, 50 mM KCl, 0.5% (w/v) Nonidet P-40, 5mM MgCl 2 , 1 mM dithiothreitol) for 12 hours. The protein was stored at -80 °C until used. ATPase activity assay -The ATPase activity of FtsH was detected by the malachite greenammonium molybdate colorimetric assay (9) . In vivo FtsH Proteolytic assay -Membrane-bound DrrAB proteins were used as a substrate to determine the proteolytic activity of FtsH. pBAD vector or the pBADftsH plasmid was transformed into AR797 cells containing pDX101 (pSU2718drrAB). The cells were grown in LB medium to mid-log phase and the DrrAB proteins were induced with 0.25 mM IPTG at 42 °C for 1 h. To terminate the synthesis of DrrAB, 1000 µg/ml chloramphenicol was added to the cell culture and incubated at 42 °C for 30 min. The cells were washed extensively to remove chloramphenicol and IPTG. After resuspending the cells in fresh medium, synthesis of FtsH from the pBADftsH plasmid was induced by addition of 0.2% arabinose at 42 °C. An aliquot of cell culture was taken out at 0, 30, 60, 90, 120 and 180 min. Membrane fractions were prepared as described above, and 20 µg total membrane protein was loaded onto 12% SDS-PAGE, followed by Western-blot analysis using anti-DrrA, anti-DrrB or anti-FtsH antibodies. (Fig. 1C, lanes 5-6) . Together, the data in Fig. 1 show that FtsH plays an important role in quality control of the DrrB protein when DrrA is absent. To rule out the possibility that DrrA or DrrB may aggregate when their expression is induced at 42 °C, the membrane, cytosol, and inclusion body fractions were prepared from both wild type and FtsH ts cells and analyzed by Western blotting using anti-DrrA and anti-DrrB antibodies. The data in Fig. 2 show that although some DrrB protein is present in the inclusion body fraction in both wild type (lower panel, lane 3) and the FtsH ts cells (lane 9) at 30 °C, the induction of either strain at 42 °C did not result in any increase in the amount of inclusion body formation (lower panel, lanes 6 and 12). Moreover, no aggregated DrrAB proteins were seen in the stacking region of the gel in any of the fractions of wild type or FtsH ts cells, indicating absence of any significant aggregation under the conditions used in these experiments. Note that the anti-DrrB antibody is an anti-peptide antibody, therefore it shows some cross-reactivity with epitopes in some other E. coli proteins, as explained in a previous publication (1) . 3B , 797/AB, filled triangles; Fig. 3C , Column 7). This effect was unexpected because DrrA and DrrB can be expressed together in the wild-type cells at 42 °C without any negative effect on their growth (Fig. 3B, 796 /AB, open rectangles; Fig. 3C , Column 6). These data indicate that the DrrAB proteins expressed in FtsH ts cells at 42 °C may be misfolded, and the accumulation of misfolded membrane proteins results in growth inhibition. It was also observed that if the FtsH ts cells initially induced at 42 °C were shifted down to 30 °C, the cell growth resumed, albeit slowly. After 43 hours of temperature shift-down, the final growth was about half as compared to the cells induced and maintained at 30 °C (data not shown), indicating that the growth inhibition of these cells is quite severe. In summary, the data in Fig. 3 suggest that FtsH is not only responsible for removing unassembled DrrB (in the absence of DrrA) but it may also be critical for proper assembly of the DrrAB complex in the membrane. 3A-B) showed that while FtsH overexpression resulted in significant proteolysis of DrrAB (Fig.  3D, lanes 3 and 7) , overexpression of GroESL did not (lanes 4 and 8) . This might imply that FtsH restores growth by simply removing misfolded DrrAB proteins, while GroESL is able to alter their conformation, thus alleviating growth inhibition. 4A-B, compare lanes 3 and 7) . These data suggest that the DrrAB proteins must acquire a partially unfolded conformation at a higher temperature (as also seen in Fig. 1B) , thus making them more susceptible to proteolysis by over-expressed FtsH. As expected, overexpression of FtsH in FtsH ts cells also showed significant proteolysis of DrrAB expressed at 42 °C (Figs. 4A-B, lanes 4 and 8) . This is consistent with the data in Fig. 3 (Fig. 4E , lower panel) resulted in increasing proteolysis of misfolded DrrA and DrrB from the membrane. At 120 minutes after addition of arabinose, about 75-80% of DrrA and DrrB were removed from the membrane. These observations are in agreement with the dislocation model proposed previously for the activity of FtsH (8) . No significant proteolysis of DrrAB was seen in the absence of FtsH synthesis (Figs. 4C and 4D, filled rectangles) .
In vitro FtsH Proteolytic assay

Expression of DrrB alone or DrrAB together in FtsH-deficient cells results in growth inhibition-
FtsH preferentially proteolyzes misfolded
The AAA domain of FtsH contains a chaperone-like activity, but it is not sufficient by itself to restore the Dox efflux function -The growth experiment in Fig. 3B suggested that FtsH may be critical for the assembly of the DrrAB complex. Further support for this idea was obtained by comparing the rate of assembly of the DrrAB complex in wild type and FtsH ts cells. The data in Fig. 5 show that the assembly of DrrA and DrrB in the membrane of FtsH ts cells is significantly compromised already at 30 °C as compared to in the wild type cells. A significant difference in the amounts of DrrAB in the membrane of wild type and mutant cells was seen at all time points tested (Fig. 5 , compare lanes 1-3 with 7-9). However, this difference is most evident at the early time points, which suggests that the rate of assembly of DrrAB is affected by FtsH. This is most likely due to the partial defect of FtsH function in FtsH ts cells already at 30 °C, leading to the low efficiency of the DrrAB complex formation.
To determine if the ability to promote assembly of DrrAB resides in the AAA domain of FtsH, variants containing mutations in the Walker A motif of the AAA domain (K198N mutation) or the conserved amino acids in the proteolytic domain (the HEH mutation and the AAA subclone are described under Methods) were created. The K198N allele contained a defective AAA domain, while the HEH mutant and the AAA subclone contained an intact AAA domain. As expected, the K198N mutation resulted in a significantly reduced ATPase activity, however the HEH mutant and the AAA subclone were unaffected ( Table 2 ). The in vitro proteolytic activity assay showed that while the wild-type FtsH completely proteolyzed α-casein in one hour, no significant reduction in the α-casein level was seen with the HEH mutant even after two hours of incubation (Fig. 6 ). These analyses confirmed that the AAA and the proteolytic domain mutants behave as expected. Therefore, they were used in two different complementation experiments (described below) to determine if the AAA domain by itself is sufficient for promoting assembly of the DrrAB complex.
The expression of the DrrAB proteins in FtsH ts cells was previously shown to result in severe growth inhibition (Fig. 3B, filled triangles) . This inhibition was reversed by simultaneous expression of FtsH (Fig. 3B, open triangles) . In the next experiment, we asked whether coexpression of the HEH allele or the AAA subclone can rescue FtsH ts cells from the growth inhibition resulting from DrrAB expression. The data in Fig.  7 show that the simultaneous expression of either the HEH mutant (Fig. 7A, open circles) or the AAA subclone (Fig. 7A, filled triangles) with DrrAB can complement the growth defect of FtsH ts cells, indicating that the AAA domain of FtsH indeed contains a chaperone-like activity. Interestingly, the HEH mutant showed much better complementation of the growth defect as compared to the AAA subclone, perhaps due to a more native conformation of the full-length HEH protein as compared to the AAA subclone. The K198N mutation, on the other hand, showed no growth complementation effect (Fig. 7A, open  triangles) , showing that the ATPase activity associated with the AAA domain is important for the chaperone function of FtsH. Western blot analysis showed that the DrrAB complex is membrane-associated in the FtsH(HEH), FtsH(AAA), and FtsH (K198N)-containing strains (Figs. 7B and 7C, lanes 5-7) , and the amounts of DrrA and DrrB in these cells were comparable to the levels in their absence (lane 3). Therefore the restoration of growth by the HEH and AAA clones must result from a change in conformation of the DrrAB proteins brought about by the functional AAA domain present in these two clones. Whether the HEH and AAA variants of FtsH can also restore function of the DrrAB complex is addressed in the next experiment.
We previously showed that the wild-type DrrA and DrrB proteins together carry out ATPdependent efflux of the anticancer drug doxorubicin (3). Here, we investigated whether co-expression of the AAA subclone or the HEH allele can restore the Dox efflux function of the misassembled DrrAB proteins expressed in FtsH ts cells at 42 °C (Fig. 8) . The data in Fig 8A indicate that the rate of DrrAB-mediated Dox efflux at 30 °C in the wild-type 796 and FtsH ts 797 cells is comparable (Columns 1 and 3) .
Induction of wild-type cells at 42 °C showed only a slight reduction in Dox efflux (Column 2), which is likely due to the destabilization effect produced by high temperature on DrrAB, as seen earlier in Figs. 1 and 4. By contrast, the FtsH ts cells induced at 42 °C showed very little or no DrrAB-mediated Dox efflux (Fig. 8A, column 4) , which was comparable to the efflux seen with control cells containing empty vector (Fig. 8A, Columns 5 and  6 ). These data confirm that the DrrAB proteins are misfolded in the absence of functional FtsH. Simultaneous overexpression of the FtsH variants, K198N, HEH or the AAA subclone, in FtsH ts cells did not restore function of misassembled DrrAB (Fig. 8B, columns 4-6) , even though restoration of growth by HEH and the AAA subclone was earlier seen in Fig. 7A . Similarly, overexpression of GroESL also did not complement the DrrABmediated Dox efflux in FtsH ts cells (Fig. 8B , column 7). One possible explanation for these data could be that even though the AAA domain of FtsH (or GroESL) is able to alter the conformation of the DrrAB proteins and relieve growth inhibition, it is not sufficient by itself to restore proper conformation required for full function of the complex.
Wild Figs. 8A and 8B) . The cells were then washed several times to remove extracellular IPTG and stop further synthesis of DrrAB. The expression of FtsH was induced by arabinose for 1 hour at 42 °C, and the cells were subjected to the Dox efflux assay. To maintain the chromosomally-encoded FtsH in an inactive conformation, the temperature was maintained at 42 °C throughout the duration of the experiment. As previously seen in Fig. 8B In the absence of arabinose induction of FtsH, much lower restoration of Dox efflux was seen (Fig. 8C , 797/AB/pBADftsH -ara, column 4). These data, therefore, show that the sequential expression of DrrAB and FtsH can still restore the function of the previously misfolded DrrAB proteins to the same (or even higher) extent as seen with simultaneous expression.
Finally, the effect of over-expression of FtsH on Dox efflux function of DrrAB expressed at different temperatures was investigated. Irrespective of whether the DrrAB proteins were induced at 30 °C, 37 °C, or 42 °C in FtsH ts cells, simultaneous expression of FtsH resulted in a very similar final Dox efflux efficiency (Fig. 8D) . At 42 °C, co-expression of FtsH enhanced Dox efflux of misfolded DrrAB 5-fold (compare columns 3 and 6), yielding about 45% Dox efflux efficiency. Interestingly, over-expression of FtsH at 30 °C or 37 °C reduced the efficiency by about half (compare columns 1-2 with 4-5), once again yielding final Dox efflux efficiency of about 45%. These results imply that FtsH produces an optimal level of functional complexes in the membrane perhaps by exerting both proteolytic and refolding effects concurrently.
DISCUSSION
Non-native proteins, especially unassembled membrane proteins, interfere with cellular processes and are known to become toxic to the cells.
Therefore, quality control systems, consisting of chaperones and proteases, play essential roles by monitoring their folding and either refolding or degrading misfolded proteins (21-23). Hsp60 (GroEL/ES) and Hsp70 (DnaK) proteins provide classical examples of ATPdependent chaperones which prevent aggregation of newly translated proteins and promote their refolding (22). A special class of chaperones (e.g. ClpB in bacteria and its homologs Hsp78 and Hsp104 in eukaryotes) is known to resolubilize protein aggregates and, in cooperation with the Hsp70 chaperones (specifically DnaKJE), can result in regaining function of the affected protein (15) . On the other end of the spectrum are proteins classically defined as proteases, for example Lon, ClpA/P, ClpX/P and FtsH, whose major function is considered to be removal of irreversibly damaged proteins from the cell (6, 14, 24) . Despite their differences, however, both classical chaperones and proteases share common features. For example, both have the ability to recognize and bind non-native polypeptides and both bring about unfolding of their substrates, which are subsequently refolded (by a chaperone) or degraded (by a protease) (12, 22, 25) .
Because of the ATPdependent unfolding function of AAA+ proteases, it has been speculated that they may also have the ability to refold substrate proteins and may participate in protein biogenesis. However, very little direct evidence is available for the role of FtsH or other AAA + proteases in biogenesis, especially of membrane protein complexes. In this study, we provide clear evidence that the E. coli FtsH is able to both degrade and refold misassembled DrrAB proteins, resulting in regaining the Dox efflux function of the membrane complex.
We show that in the absence of the DrrA protein, DrrB acquires an FtsH-sensitive conformation and is completely proteolyzed. However, in the absence of functional FtsH, the DrrB protein accumulates even in the absence of DrrA confirming that FtsH monitors the folding status of DrrB and removes it if it is improperly assembled. The molecular details of proteolysis of DrrB by FtsH are currently unknown, however based on the prevalent model for its action (8, 26) we assume that FtsH could initiate proteolysis of DrrB either at the N-or the C-terminal end (both of which are found in the cytoplasm, (27)). Crosslinking studies previously showed that the N terminus of DrrB is the major site of interaction with DrrA (3,27); therefore we propose that proteolysis of DrrB initiates at its N-terminal tail, and binding of DrrA to this region of DrrB protects it from proteolysis by FtsH.
Interestingly, we found that the function of FtsH is not limited to proteolysis of unassembled DrrB, but it also plays an essential role in folding and assembly of the DrrAB complex. This conclusion is supported by several lines of evidence presented in this paper. First, the expression of DrrA and DrrB together in FtsH ts cells at 42 °C (which results in inactivation of FtsH) was found to be growth inhibitory (Fig. 3B) suggesting that the complex is improperly assembled in the absence of a functional FtsH. Second, the rate of assembly of the DrrAB complex in the FtsH ts cells at 30 °C was found to be significantly reduced as compared to the wildtype cells (Fig. 5) . Third, functional analysis showed complete absence of the DrrAB-mediated Dox efflux in FtsH ts cells under conditions of FtsH inactivation, suggesting that most or all of the DrrAB proteins expressed in these cells at 42 °C are misassembled.
By contrast, the DrrAB proteins expressed in wild-type cells at 42 °C retained on average 85-90% of the Dox efflux activity (Fig. 8A) . Finally, co-expression of FtsH in trans in FtsH ts cells restored the ability of DrrAB to carry out Dox efflux, confirming that FtsH facilitates assembly of the DrrAB complex (Fig. 8B) . Nevertheless, this result was surprising because FtsH contains a functional proteolytic domain. It's overexpression in FtsH ts cells results in proteolysis of the misfolded DrrAB proteins (as seen in Fig. 4 ), however the data in Fig. 8B show that FtsH also facilitated some folding resulting in about 45% recovery of the Dox efflux activity. Either the AAA domain by itself or the GroESL chaperone was unable to complement the Dox efflux function of DrrAB in FtsH ts cells, even though each was able to alleviate the growth defect. Therefore, together these data suggest that both the AAA and the protease domains of FtsH are essential for promoting functional assembly of DrrAB.
The most crucial evidence for the refolding function of FtsH, however, came from the sequential expression studies. Irrespective of whether FtsH was expressed simultaneously with DrrAB or expressed after the non-functional DrrA and DrrB proteins had already accumulated in FtsH ts cells, it was able to restore the function of the complex (Fig. 8C) , thus showing conclusively that FtsH not only facilitates assembly of the DrrAB complex but it is also actively involved in refolding previously misassembled DrrAB proteins. Interestingly, we also found that the sequential expression of DrrAB and FtsH resulted in a significantly higher recovery of the Dox efflux function of DrrAB as compared to simultaneous expression (Fig. 8C ). This finding suggests that FtsH treats its substrate differently during its synthesis as compared to after it has already been synthesized.
In summary, our studies confirm that the AAA domain of FtsH can recognize and bind substrates and change their conformation, which is in agreement with the previous studies (18) . However, we also show that the two activities (ATPase and proteolytic) of FtsH must be present simultaneously and occur in a coordinated manner to facilitate assembly and refolding of DrrAB. Much more extensive analysis will be required in the future to understand the nature of the molecular processes involved in refolding of DrrA and DrrB and to determine if other factors also play a role in the assembly of the DrrAB complex. Further studies will also provide clues about how degradation and assembly of multi-subunit complexes are regulated, and whether other AAA+ proteases may also contain chaperone activity. This study raises intriguing questions about the distinction between classical chaperones like GroESL (that can prevent aggregation of many proteins) and the classical proteases like FtsH that not only carry out proteolysis but also actively participate in refolding of their specific substrates, as shown in this study. Bukau and Mogk previously (22) coined four terms to describe the various activities of chaperones and proteases: Holders (small heat shock proteins, Hsps), Folders (GroESL and DnaK), Unfolders (ClpA, ClpX, and ClpB), and Proteases (Lon, ClpP, and FtsH). In light of the findings reported in this article, we prepared from sample #s 6-9 collected at the 4 hour time point in Fig. 3A and 3B. Western blot analysis was carried out as in Fig. 1(A) . 
